Potential increase in androgen sensitivity following antisense oligonucleotide suppression of Bcl-2 in a prostate cancer model.

被引：0
|
作者：
Guinan, Patrick
Rubenstein, Marvin
Hollowell, Courtney M. P.
机构：
[1] Hektoen Inst Med Res, Chicago, IL 60612 USA
[2] John H Stroger Jr Hosp Cook Cty, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13532
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Downregulation of BCL-2 expression by the antisense oligonucleotide G3139 enhances paclitaxel chemosensitivity in the androgen-independent prostate cancer LNCaP xenograft model.
    Tolcher, AW
    Miyake, H
    Gleave, M
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 : 3847S - 3847S
  • [2] iNOS expression is not regulated by ligand activation of the androgen receptor or bcl-2 in a prostate cancer cell line model.
    Moledina, J
    ElSheikh, SS
    Abel, P
    Stamp, G
    Lalani, EN
    [J]. JOURNAL OF PATHOLOGY, 2001, 195 : 15A - 15A
  • [3] Targeting bcl-2 gene to delay androgen-independent progression and enhance chemosensitivity in prostate cancer using antisense bcl-2 oligodeoxynucleotides
    Gleave, ME
    Miayake, H
    Goldie, J
    Nelson, C
    Tolcher, A
    [J]. UROLOGY, 1999, 54 (6A) : 36 - 46
  • [4] Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides
    Miayake, H
    Tolcher, A
    Gleave, ME
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (01) : 34 - 41
  • [5] Antisense Bcl-2 sensitizes prostate cancer cells to radiation
    Mu, ZM
    Hachem, P
    Pollack, A
    [J]. PROSTATE, 2005, 65 (04): : 331 - 340
  • [6] Antisense Bcl-2 and HER-2 oligonucleotide, treatment of breast cancer cells enhances their sensitivity to anticancer drugs
    Tanabe, K
    Kim, R
    Inoue, H
    Emi, M
    Uchida, Y
    Toge, T
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 22 (04) : 875 - 881
  • [7] Enhanced expression of bcl-2 following antisense oligonucleotide mediated growth factor deprivation
    Rubenstein, M
    Chou, P
    Mirochnik, Y
    Guinan, P
    [J]. MEDICAL ONCOLOGY, 1997, 14 (01) : 23 - 29
  • [8] Enhanced expression of bcl-2 following antisense oligonucleotide mediated growth factor deprivation
    Marvin Rubenstein
    Pauline Chou
    Yelena Mirochnik
    Patrick Guinan
    [J]. Medical Oncology, 1997, 14 : 23 - 29
  • [9] Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy
    Kim, R
    Emi, M
    Tanabe, K
    Toge, T
    [J]. CANCER, 2004, 101 (11) : 2491 - 2502
  • [10] Antisense to bcl-2 (Genasense™) sensitizes prostate cancer cells to radiation
    Mu, Z
    Hachem, P
    Pollack, A
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S176 - S177
12345